JeenJoo Kang - Aug 3, 2021 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Director
Signature
/s/ Leone Patterson Attorney-in-Fact for JeenJoo Kang
Stock symbol
TNYA
Transactions as of
Aug 3, 2021
Transactions value $
$0
Form type
4
Date filed
8/4/2021, 06:30 PM
Previous filing
Jul 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNYA Common Stock Conversion of derivative security $0 +12.5K +100% $0.00 25K Aug 3, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNYA Series A Preferred Stock Conversion of derivative security -12.5K -100% 0 Aug 3, 2021 Common Stock 12.5K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock automatically converted into one share of common stock immediately prior to the completion of the Issuer's initial public offering, and had no expiration date.